-

Trinity Life Sciences Appoints Aparna Deshpande as Head of Analytics & Insights

The Predictive Power of Layering Insights and Analytics Set to Transform the Life Sciences Industry

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, announces the appointment of Aparna Deshpande to Senior Partner and Head of Analytics & Insights. Ms. Deshpande had previously been Senior Partner and Head of Insights for the Company. The added responsibility of leading the Analytics business represents the overall benefits that life science companies can achieve when weaving the power of insights with accurate analytics.

“Leveraging the predictive power of data-driven insights for our clients is what sets us apart from other companies. With the appointment of Aparna as leader of both our Insights and Analytics businesses, we will transform the way our clients make critical decisions saving them both time and money,” said Leslie Orne, President and CEO of Trinity Life Sciences. “Aparna and her teams will be at the forefront of that transformation.”

Ms. Deshpande plans to focus on three specific analytics areas important to life science companies that will be driven by tech solutions and AI:

  • Data Orchestration
  • Commercial Analytics
  • Customer Engagement

“Combining the rich context of data, layering it with the forward-looking elements of market research and then adding seamless AI-driven tools a life science executive can easily use to digest the information creates a reliable crystal ball,” said Aparna Deshpande, Senior Partner and Head of Analytics & Insights. “This foundational data fabric that combines both the “what” and the “why” of customer behavior is a significant differentiator for us – no one else can offer this type of single source of truth for life science companies.”

Deep Industry Roots Combined with Novel Technology

For almost thirty years, Trinity has focused exclusively on the life sciences space, allowing the business to build up its industry expertise. This knowledge fuels its AI and tech offerings in an immediately actionable way for clients. From strategic planning to tactical execution and across a full product life cycle, Trinity’s core competency is providing services that leverage analytics and insights. Trinity’s focus under the direction of Ms. Deshpande will be on continuing to enhance the speed and ability to scale in delivering data, analytics and insights to drive its clients’ clinical and commercial success.

About Trinity Life Sciences

With almost 30 years of expertise, a best-in-the-business team and unrivaled access to data and analytics, Trinity Life Sciences is a modern partner to companies in the life sciences industry. Trinity combines strategy, insights and analytics to help life science executives with clinical and commercial decision-making. We serve over 300 pharmaceutical, biotech and medical device clients, helping them develop the right drugs and devices for today’s market and optimize them once in market. We have a diverse staff of over 1200 people and 11 global offices across the U.S., Europe and Asia. Ultimately, we know that every decision our clients make impacts a life, and when we help our clients achieve their goals, the world benefits. To learn more about how Trinity is elevating the industry and driving evidence to action, visit TrinityLifeSciences.com.

Contacts

Media Contact:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Versions

Contacts

Media Contact:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Social Media Profiles
More News From Trinity Life Sciences

Trinity Appoints Scott Evangelista as CEO to Lead Next Chapter

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced Scott Evangelista has been appointed Chief Executive Officer, succeeding Leslie Orne who is stepping down after three years as CEO and over 24 years with the company. Ms. Orne will transition to the role of Senior Advisor and serve as a member of Trinity’s Board of Directors. Over her distinguished tenure, Ms. Orne helped guide Trinity’s evo...

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization, today announced the release of its 5th Annual TGaS Digital Marketing Competency Report, a three-part series benchmarking the digital marketing presence of more than 150 biopharma brands. The 2025 edition reveals a significant leap forward in the industry’s digital sophistication, with a 19% increase in Proficient brands and a surge of innovation in patient engagement strategies. The report ranks each b...

Trinity Expands Global Footprint with Acquisition of EVERSANA’s APACME Advisory Services

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization solutions and recognized for being a strategic, tech-enabled commercialization company that empowers pharma, biotech, and medtech organizations to advance medical innovations, announced today the acquisition of EVERSANA’s advisory services operation in Asia-Pacific and the Middle East (APACME). The strategic acquisition will transition EVERSANA’s advisory services operation in APACME to Trinity, further...
Back to Newsroom